Phenard Odero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Phenard Odero has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Afe Victor Dania
Bayelsa Medical University, Yenagoa, Nigeria
1 shared publication - Alphonsinah Moogi
Lions Sightfirst Eye hospital, Nairobi, Nairobi, Kenya
1 shared publication - Emmanuel Elochukwu Okenwa-Vincent
Department of Optometry and Vision Sciences Kaimosi Friends University Kaimosi Kenya
1 shared publication - Khathutshelo Percy Mashige
Discipline of Optometry, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
1 shared publication
Latest Publications
- Open Access
- 16 February 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 185
Effects of Ganoderma lucidum on chemical-induced and bacterial-infected corneal ulceration of rabbits’ eyes
Background: Corneal ulcerations pose risks to blindness, and their treatment presents huge challenges, in part due to increased resistance to anti-bacterial drugs, accessibility and cost issues, particularly in developing countries. This study investigated the pharmacological effect of Ganoderma Lucidum, on chemical-induced and bacterial-infected corneal ulceration of rabbits’ eyes. Methods: This was a randomized-controlled experiment of 16 healthy New Zealand rabbits, randomly assigned into four groups (A–D). The right eye cornea was injured using a drop of 1 Molar sodium hydroxide and followed by infection with Pseudomonas aeruginosa after 12 hours, in all groups except group A. Treatment with freshly prepared crude aqueous extract of G. lucidum (40 μg/mL) for groups A and B, the standard treatment protocol for group C, and atropine alone for group D commenced after 24 hours and continued every four hours for seven days. All data collected, pre-and post-tests, were analysed at α=0.05 using Wilcoxon signed-rank test for correlated variables and the Mann–Whitney U test for independent variables. Results: G. lucidum has significant clinical effects (74%) on corneal injury and ulcers (92%). The healing effects observed at the 168th hour were significantly better than those observed at the 24th hour (p0.05), the mean effect size was clinically significant (31%). Conclusion: This study demonstrates the potential antimicrobial potential of G. lucidum. G. lucidum may provide an alternative treatment option for chemical-induced and bacterial-infected corneal ulcers, particularly in resource-constrained countries.
- 16 February 2023
- Published by F1000 Research Ltd in F1000Research
- Vol. 12, 185
Open AccessEffects of Ganoderma lucidum on chemical-induced and bacterial-infected corneal ulceration of rabbits’ eyes
Background: Corneal ulcerations pose risks to blindness, and their treatment presents huge challenges, in part due to increased resistance to anti-bacterial drugs, accessibility and cost issues, particularly in developing countries. This study investigated the pharmacological effect of Ganoderma Lucidum, on chemical-induced and bacterial-infected corneal ulceration of rabbits’ eyes. Methods: This was a randomized-controlled experiment of 16 healthy New Zealand rabbits, randomly assigned into four groups (A–D). The right eye cornea was injured using a drop of 1 Molar sodium hydroxide and followed by infection with Pseudomonas aeruginosa after 12 hours, in all groups except group A. Treatment with freshly prepared crude aqueous extract of G. lucidum (40 μg/mL) for groups A and B, the standard treatment protocol for group C, and atropine alone for group D commenced after 24 hours and continued every four hours for seven days. All data collected, pre-and post-tests, were analysed at α=0.05 using Wilcoxon signed-rank test for correlated variables and the Mann–Whitney U test for independent variables. Results: G. lucidum has significant clinical effects (74%) on corneal injury and ulcers (92%). The healing effects observed at the 168th hour were significantly better than those observed at the 24th hour (p0.05), the mean effect size was clinically significant (31%). Conclusion: This study demonstrates the potential antimicrobial potential of G. lucidum. G. lucidum may provide an alternative treatment option for chemical-induced and bacterial-infected corneal ulcers, particularly in resource-constrained countries.